is semaglutide on backorder People who order low-cost versions of the wildly popular weight-loss drugs Wegovy and Zepbound from so-called compounding pharmacies might soon see disruptions in their medication. The U.S. Food and Drug Administration recently The weight loss drug shortage

Both medications carry warnings for potential thyroid tumors (medullary thyroid carcinoma), pancreatitis, kidney disease (including acute kidney injury and worsening kidney disease) and allergic reactions

But based on his labs research, he said, one of my favorite theories is inflammation, because we know that people with cardiovascular disease do have increased inflammation in their blood vessels and in the heart. Get CNN Health's weekly newsletter Sign up here to get The Results Are In with Dr

Grounded in science and compassion, Helen helps readers build habits that support lasting change beyond the medication itself

Talk to your provider about prescribing with us, we look forward to serving you

Trial design: 2,339 participants Adults with obesity or overweight + at least one weight-related complication Participants did NOT have diabetes Randomized to placebo or retatrutide 4 mg, 9 mg or 12 mg 80-week double-blind trial Pre-specified extension to 104 weeks in participants with BMI 35 Weight loss results at 80 weeks: 4 mg: -19.0% (~47 lbs / 21.4 kg) 9 mg: -25.9% (~64 lbs / 29.2 kg) 12 mg: -28.3% (~70 lbs / 31.9 kg) That degree of weight loss approaches levels traditionally associated with bariatric surgery

Our treatments are administered by trained medical professionals using medical-grade ingredients and sterile equipment